u Our Journey - Ytiliga
 

Our Journey

Home Our Journey

A Path of Innovation and Excellence

Ytiliga Private Limited embarked on its journey on 09 May 2016 with a clear vision: to revolutionize the pharmaceutical landscape by delivering innovative and high-quality healthcare solutions. Our journey reflects a commitment to evolving and expanding, always driven by a core principle—agility.

Explore Our History

2018

Urology

In 2018, we marked a significant milestone with the introduction of our urology range under the division Urology. This expansion represented our first major foray beyond gynaecology, focusing on addressing a variety of urological conditions. With a portfolio of innovative products, Urology aimed to improve patient outcomes and set new benchmarks in urology.

2020

NephroTron™

Building on our success in urology, 2020 saw the launch of our nephrology range under NephroTron™. This division was dedicated to advancing treatments for kidney-related conditions, leveraging cutting-edge research and technology to enhance patient care.

2022

UroOncology

In 2022, we took another significant step by expanding Urology to include the uro-oncology range. This strategic addition underscored our commitment to addressing complex health issues, providing specialized treatments for cancers of the urinary system, and continuing our journey of innovation.

2024

AndroXprts™

The first half of 2024 marked the launch of AndroXprts™, a new vertical under Urology. Targeting the previously unaddressed market of andrology, AndroXprts™ represents our dedication to pioneering research and solutions for male reproductive health.

2024

CNStron™

In the latter half of 2024, we introduced CNStron™, a new division focused on neurology specialty drugs. This addition reflects our ongoing commitment to comprehensive healthcare solutions, bringing advanced neurological treatments to patients and further expanding our impact.

Our Commitment

From our early days focusing on gynaecology to our latest innovations in neurology, Ytiliga Private Limited’s journey is characterized by a relentless pursuit of excellence and innovation. We continue to build on our core values of agility, quality, and research-driven solutions, ensuring that we remain at the forefront of the pharmaceutical industry and make a meaningful impact on global healthcare.

Explore our journey and join us as we continue to push boundaries and deliver high-quality healthcare solutions that make a difference.